<!DOCTYPE html>
<html lang="en">

<head>
  <meta charset="utf-8">
  <meta content="width=device-width, initial-scale=1.0" name="viewport">

  <title> Journal - Biostatistics & Data Science Innovation Lab</title>
  <meta content="" name="description">
  <meta content="" name="keywords">

  <!-- Favicons -->
  <link href="assets/img/favicon.png" rel="icon">
  <link href="assets/img/apple-touch-icon.png" rel="apple-touch-icon">

  <!-- Google Fonts -->
  <link
    href="https://fonts.googleapis.com/css?family=Open+Sans:300,300i,400,400i,600,600i,700,700i|Nunito:300,300i,400,400i,600,600i,700,700i|Poppins:300,300i,400,400i,500,500i,600,600i,700,700i"
    rel="stylesheet">

  <!-- Vendor CSS Files -->
  <link href="assets/vendor/bootstrap/css/bootstrap.min.css" rel="stylesheet">
  <link href="assets/vendor/bootstrap-icons/bootstrap-icons.css" rel="stylesheet">
  <link href="assets/vendor/aos/aos.css" rel="stylesheet">
  <link href="assets/vendor/remixicon/remixicon.css" rel="stylesheet">
  <link href="assets/vendor/swiper/swiper-bundle.min.css" rel="stylesheet">
  <link href="assets/vendor/glightbox/css/glightbox.min.css" rel="stylesheet">

  <!-- Template Main CSS File -->
  <link href="assets/css/style.css" rel="stylesheet">
  <link rel='stylesheet' type='text/css' href='assets/css/style.min.css'>

  <!-- =======================================================
  * Template Name: FlexStart - v1.2.0
  * Template URL: https://bootstrapmade.com/flexstart-bootstrap-startup-template/
  * Author: BootstrapMade.com
  * License: https://bootstrapmade.com/license/
  ======================================================== -->
</head>

<body>

  
  <!-- ======= Header ======= -->
  <header id="header" class="header fixed-top">
    <div class="
          container-fluid container-xl
          d-flex
          align-items-center
          justify-content-between">

      <a href="index.html" class="logo d-flex align-items-center">
        <img src="assets/img/logo.png" alt="" />
      </a>
  
      <nav id="navbar" class="navbar">
        <ul>
          <li class="dropdown">
            <a style="color: #fff" href="#"><span>Introduction</span> <i class="bi bi-chevron-down"></i></a>
            <ul>
              <li><a href="contact.html">Contact</a></li>
            </ul>
          </li>
  
          <li class="dropdown">
            <a style="color: #fff" href="research.html"><span>Research</span> <i class="bi bi-chevron-down"></i></a>
            <ul>
              <li class="dropdown">
                <a href="research1.html"><span>Domain Research</span>
                </a>
              </li>
              <li class="dropdown">
                <a href="research2.html"><span>Methodology Development</span>
                </a>
              </li>
            </ul>
          </li>
          <li class="dropdown">
            <a style="color: #fff" href="#"><span>Members</span> <i class="bi bi-chevron-down"></i></a>
            <ul>
              <li><a href="professor.html">Professor</a></li>
              <li><a href="members.html">Members</a></li>
              <li><a href="alumni.html">Alumni</a></li>
            </ul>
          </li>
  
          <li class="dropdown">
            <a style="color: #fff" href="#"><span>Publications</span> <i class="bi bi-chevron-down"></i></a>
            <ul>
              <li><a href="journal.html">Journal</a></li>
              <li><a href="conference1.html">Conference</a></li>
            </ul>
          </li>
  
          <li class="dropdown">
            <a style="color: #fff" href="#"><span>Board</span> <i class="bi bi-chevron-down"></i></a>
            <ul>
              <li><a href="gallery.html">Gallery</a></li>
              <li><a href="news.html">News &amp; Notice</a></li>
            </ul>
          </li>
        </ul>
        <i class="bi bi-list mobile-nav-toggle"></i>
      </nav>
      <!-- .navbar -->
    </div>
  </header>
  <!-- End Header -->

  <section class="page-title centred">
    <div class="container">
      <div class="content-box">
        <div class="title">Journal</div>
        <ul class="bread-crumb">
          <li><a href="">Home</a></li>
          <li><a href="news.html">Publications</a></li>
          <li>Journal</li>
        </ul>
      </div>
    </div>
  </section>

    <div class="prof">
      <div class="part1_">
        <div class="p1_right">
        </div>
      </div>
      <div class="part2">
        <div class="p2_list" style="padding:15px;" data-aos="fade-down" data-aos-duration="1000">
          <h3>2021</h3>
          <p> Impact of comorbidity Accessment methods to predict non-cancer mortality risk in cancer patients: a
            retrospective observational study using the National Health Insurance Service claims-based data in Korea.
            BMC medical research methodology 21.1 (2021): 1-9.</p>
          <p> A Statistician Teaches Deep Learning. Journal of Statistical Theory and Practice 15.2 (2021): 1-23.</p>
          <p> Incidence of venous thromboembolism after standard treatment in patients with epithelial ovarian cancer in
            Korea. Cancer medicine 10.6 (2021): 2045-2053</p>
        </div>
        <div class="p2_list" style="padding:15px;" data-aos="fade-down" data-aos-duration="1000">
          <h3>2020</h3>
          <p>Binary genetic algorithm for optimal joinpoint detection: Application to cancer trend analysis: STATISTICS
            IN MEDICINE. 40(3):799~822 </p>
          <p> Utility of the Patient-Reported Outcomes Measurement Information System (PROMIS) to measure primary health
            outcomes in cancer patients: a systematic review: SUPPORTIVE CARE IN CANCER. Online:Published </p>
          <p>Association between viral hepatitis infection and Parkinson's disease: A population?based prospective
            study: JOURNAL OF VIRAL HEPATITIS. Online:Published </p>
          <p>Cumulative incidence of chemotherapy-induced cardiotoxicity during a 2-year follow-up period in breast
            cancer patients: BREAST CANCER RESEARCH AND TREATMENT. 182(2):333~343 </p>
          <p> Omental Free-Shaped Flap Reinforcement on Anastomosis and Dissected Area (OFFROAD) Following
            Reconstruction after Gastrectomy: A Retrospective Case-Control Study: JOURNAL OF MINIMALLY INVASIVE SURGERY.
            23(1):22~29 (0) </p>
          <p> Applications of competing risks analysis in public health: JOURNAL OF THE KOREAN STATISTICAL SOCIETY.
            Online:Published </p>
          <p>Causes of death among cancer patients in the era of cancer survivorship in Korea: Attention to the suicide
            and cardiovascular mortality: CANCER MEDICINE. 9(5):1741~1752</p>
          <p> Prognostic implications of the eighth edition of the union for international cancer control -
            classification for gastric cancer patients from specialized treatment centers in Germany and Korea: A
            STOBE-Compliant large-scale cohort study.: MEDICINE. 99(6):e18922 </p>
          <p> Pulmonary Tuberculosis is Associated with Elevated Risk of Lung cancer in Korea: The Nationwide Cohort
            Study: JOURNAL OF CANCER. 11(7):1899~1906</p>
        </div>
        <div class="p2_list" style="padding:15px;" data-aos="fade-down" data-aos-duration="1000">
          <h3>2019</h3>
          <p> Analyzing discrete competing risks data with partially overlapping or independent data sources and
            nonstandard sampling schemes, with application to cancer registries: Statistics in Medicine.
            38(29):5528~5546 </p>
          <p> Estimation of covariance matrix of multivariate longitudinal data using modified Choleksky and hypersphere
            decompositions: Biometrics. Online:Published </p>
          <p> Effect of Antihypertensive Medications on Sepsis-Related Outcomes: A Population-Based Cohort Study:
            Critical Care Medicine. 47(5):e386~e393</p>
          <p> Prognostic Value of Post-Diagnosis Health-Related Quality of Life for Overall Survival in Breast Cancer:
            Findings from a 10-Year Prospective Cohort in Korea: CANCER RESEARCH AND TREATMENT. Online:Published</p>
        </div>
        <div class="p2_list" style="padding:15px;" data-aos="fade-down" data-aos-duration="1000">
          <h3>2018</h3>
          <p> Serum ferritin level is associated with liver steatosis and fibrosis in Korean general population:
            Hepatology International. 13(2):222~233</p>
          <p> Incidence and Overall Survival of Biliary Tract Cancers in South Korea from 2006 to 2015: Using the
            National Health Information Database.: Gut and Liver. 13(1):104~113</p>
          <p> Doxorubicin-induced heart failure in cancer patients: A cohort study based on the Korean National Health
            Insurance Database: CANCER MEDICINE. 7(12):6084~6092</p>
          <p> Accelerated failure time models for the analysis of competing risks: The Joirnal of the Korean Statistical
            Society. Online:Published</p>
          <p> Socioeconomic Inequalities in Colorectal Cancer Screening in Korea, 2005-2015: After the Introduction of
            the National Cancer Screening Program: YONSEI MEDICAL JOURNAL. 59(9):1034~1040</p>
          <p> SCI Socioeconomic Inequalities in Cervical and Breast Cancer Screening among Women in Korea, 2005-2015:
            YONSEI MEDICAL JOURNAL.</p>
          <p> Socioeconomic Inequalities in Stomach Cancer Screening in Korea, 2005-2015: After the Introduction of the
            National Cancer Screening Program: YONSEI MEDICAL JOURNAL. 59(8):923~929 </p>
          <p> Increasing Trend in Hospital Deaths Consistent among Older Decedents in Korea: A Population-based Study
            Using Death Registration Database, 2001?2014: BMC palliative care.2018(17):16~16</p>
          <p> Health Behavior Associated Liver Enzymes among Obese Korean Adolescents, 2009-2014: PLoS One.
            13(1):e0190535~e0190535</p>
        </div>
        <div class="p2_list" style="padding:15px;" data-aos="fade-down" data-aos-duration="1000">
          <h3>2017</h3>
          <p> Beliefs and Intentions to Undergo Lung Cancer Screening among Korean Males: Cancer Research and Treatment.
            50(4):1096~1105</p>
          <p>Nationwide Trends in the Incidence of Melanoma and Non-melanoma Skin Cancers from 1999 to 2014 in South
            Korea: Cancer research and treatment. 50(3):729~737</p>
          <p> Risk of diabetes in viral hepatitis B or C patients compared to that in noninfected individuals in Korea,
            2002-2013: A population-based cohort study.: Journal of Viral Hepatitis. 25(3):272~280</p>
          <p> Calculating life expectancy to inform prostate cancer screening and treatment decisions: BJU
            International. 120(1):9~11</p>
          <p> Sex Disparity in Survival of Patients With Uveal Melanoma: Better Survival Rates in Women Than in Men in
            South Korea: Investigative Ophthalmology & Visual Science. 58(3):1909~1915</p>
        </div>
        <div class="p2_list" style="padding:15px;" data-aos="fade-down" data-aos-duration="1000">
          <h3>2016</h3>
          <p> Trends and Age-Period-Cohort Effects on the Incidence and Mortality Rate of Cervical Cancer in Korea:
            Cancer Research and Treatment. 49(2):526~533</p>
          <p> Association between screening and the thyroid cancer “epidemic” in South Korea: evidence from a nationwide
            study: British Medical Journal. 355:i5745~i5745</p>
          <p> Current Trends in the Incidence and Survival Rate of Urological Cancers in Korea: Cancer Research and
            Treatment. Online:Published</p>
          <p>Prediction of Cancer Incidence and Mortality in Korea, 2016: Cancer research and treatment. 48(2):451~457
          </p>
          <p>Cancer Statistics in Korea: Incidence, Mortality, Survival, and Prevalence in 2013: Cancer Research and
            Treatment. 48(2):436~450</p>
        </div>
        <div class="p2_list" style="padding:15px;" data-aos="fade-down" data-aos-duration="1000">
          <h3>2015</h3>
          <p>Alanine aminotransferase and gamma-glutamyl transferase have different dose-response relationships with
            risk of mortality by age: Liver international. 36(1):126~135</p>
          <p>Do US thyroid cancer incidence rates increase with socioeconomic status among people with health insurance?
            An observational study using SEER population-based data: BMJ Open. 5(12):e009843~e009843</p>
          <p>Risk of Second Primary Cancer among Prostate Cancer Patients in Korea: A Population-Based Cohort Study:
            PLOS ONE. 10(10):e0140693~e0140693</p>
          <p> Nationwide Incidence of Ocular Melanoma in South Korea by Using the National Cancer Registry Database
            (1999-2011): Investigative ophthalmology & visual science. 56(8):4719~4724</p>
          <p>Prediction of Cancer Incidence and Mortality in korea, 2015: Cancer research and treatment. 47(2):142~148
          </p>
          <p> Cancer Statistics in Korea: Incidence, Mortality, Survival, and Prevalence in 2012: Cancer research and
            treatment. 47(2):127~141</p>
          <p>Cancer risk factors in Korean news media: a content analysis: Asian Pacific journal of cancer prevention.
            16(2):731~736</p>
        </div>
        <div class="p2_list" style="padding:15px;" data-aos="fade-down" data-aos-duration="1000">
          <h3>2014</h3>
          <p> The Impact of State-Specific Life Tables on Relative Survival: Journal of the National Cancer Institute.
            Monographs. 2014(49):218~227</p>
          <p> Cancer Survival: An Overview of Measures, Uses, and Interpretation: Journal of the National Cancer
            Institute. Monographs. 2014(49):145~186</p>
          <p>When Do Changes in Cancer Survival Mean Progress? The Insight From Population Incidence and Mortality:
            Journal of the National Cancer Institute. Monographs. 2014(49):187~197</p>
          <p> Annual Report to the Nation on the Status of Cancer, 1975-2010, Featuring Prevalence of Comorbidity and
            Impact on Survival Among Persons With Lung, Colorectal, Breast, or Prostate Cancer: Cancer. 120(9):1290~1314
          </p>
          <p> Developments and challenges in statistical methods in cancer surveillance: Statistics and Its Interface.
            7(1):135~151</p>
        </div>
        <div class="p2_list" style="padding:15px;" data-aos="fade-down" data-aos-duration="1000">
          <h3>2013</h3>
          <p> Life tables adjusted for comorbidity more accurately estimate noncancer survival for recently diagnosed
            cancer patients: Journal of Clinical Epidemiology. 66:1376~1385</p>
          <p> Assessing Non-Cancer-Related Health Status of US Cancer Patients: Other-Cause Survival and Comorbidity
            Prevalence: American Journal of Epidemiology. 178:339~349</p>
          <p> Comorbidity-Adjusted Life Expectancy: A New Tool to Inform Recommendations for Optimal Screening
            Strategies: Annals of Internal Medicine. 159:667~676 </p>
          <p> SEER Cancer Statistics Review, 1975-2010: US Government Report National Cancer Institute. Bethesda, MD,
            USA. Online:Published</p>
        </div>
        <div class="p2_list" style="padding:15px;" data-aos="fade-down" data-aos-duration="1000">
          <h3>2012</h3>
          <p> Perturbation and Scaled Cook’s Distance: Annals of Statistics. 40:785~811</p>
          <p> Bayesian Case Influence Measures for Statistical Models with Missing Data: Journal of Computational and
            Graphical Statistics. 21:253~271</p>
          <p> Cancer Treatment and Survivorship Statistics: CA: A Cancer Journal for Clinicians. 62:220~241</p>
          <p> SEER Cancer Statistics Review, 1975-2009 (Vintage 2009 Populations): US Government Report National Cancer
            Institute. Bethesda, MD, USA. Online:Published</p>
        </div>
        <div class="p2_list" style="padding:15px;" data-aos="fade-down" data-aos-duration="1000">
          <h3>2011</h3>
          <p> SEER Cancer Statistics Review, 1975-2008: US Government Report National Cancer Institute. Bethesda, MD,
            USA. Online:Published</p>
          <p> Estimating relative survival for cancer patients from the SEER Program using expected rates based on
            Ederer I versus Ederer II method: Surveillance Research Program, National Cancer Institute, USA Technical
            Report #2011-01. Online:Published</p>
        </div>
        <div class="p2_list" style="padding:15px;" data-aos="fade-down" data-aos-duration="1000">
          <h3>2010</h3>
          <p> SEER Cancer Statistics Review, 1975-2007: US Government Report National Cancer Institute, Bethesda, MD,
            USA. Online:Published</p>
        </div>
        <div class="p2_list" style="padding:15px;" data-aos="fade-down" data-aos-duration="1000">
          <h3>2009</h3>
          <p> Expression of p16INK4a in peripheral blood T-cells is a biomarker of human aging: Aging Cell. 8:439~448
          </p>
          <p> INK4/ARF transcript expression is associated with chromosome 9p21variants linked to atherosclerosis: PLoS
            ONE. 4:1~5</p>
          <p> Bayesian Case Influence Diagnostics for Survival Models: Biometrics. 65:116~124</p>
        </div>
        <div class="p2_list" style="padding:15px;" data-aos="fade-down" data-aos-duration="1000">
          <h3>2008</h3>
          <p> Early Treatment-Related Changes in Diabetes and Cardiovascular Disease Risk Markers in First Episode
            Psychosis Subjects: Schizophrenia Research. 101:287~294</p>
        </div>
        <div class="p2_list" style="padding:15px;" data-aos="fade-down" data-aos-duration="1000">
          <h3>2005</h3>
          <p> Prevalence of Symptomatic Diastolic Heart Failure in Patients Hospitalized with Cerebral or Peripheral
            Vascular Disease: Congestive Heart Failure. 11:256~261</p>
        </div>
      </div>

  <br>
  <br>
  <br>

  <!-- ======= Footer ======= -->
  <footer id="footer" class="footer">
    <div class="footer-top">
      <div class="container">
        <div class="row gy-4">
          <div class="col-lg-5 col-md-12 footer-info">
            <a href="index.html" class="logo d-flex align-items-center">
              <img src="assets/img/logo.png" alt="" />
            </a>
          </div>
  
          <div class="col-lg-2 col-6 footer-links">
            <h4>Menu</h4>
            <ul>
              <li>
                <i class="bi bi-chevron-right"></i>
                <a href="index.html">Home</a>
              </li>
              <li>
                <i class="bi bi-chevron-right"></i>
                <a href="aboutus.html">About us</a>
              </li>
            </ul>
          </div>
  
          <div class="col-lg-2 col-6 footer-links">
            <h4>Cooperation</h4>
            <ul>
              <li>
                <i class="bi bi-chevron-right"></i>
                <a href="#">National Cancer Center</a>
              </li>
              <li>
                <i class="bi bi-chevron-right"></i> <a href="#">NCC-GCSP</a>
              </li>
            </ul>
          </div>
  
          <div class="
                  col-lg-3 col-md-12
                  footer-contact
                  text-center text-md-start
                ">
            <h4>Contact Us</h4>
            <p>
              323 Illsan-ro, Illsandong-gu <br />
              Goyang-si, Gyeongggi-do 10408<br />
              Republic of Korea <br /><br />
              <strong>Phone:</strong> +1 5589 55488 55<br />
              <strong>Email:</strong> info@ncc.re.kr<br />
            </p>
          </div>
        </div>
      </div>
    </div>
  
    <div class="container">
      <div class="copyright">
        &copy; Copyright <strong><span>BDSI</span></strong>. All Rights Reserved
      </div>
    </div>
  </footer>
  <!-- End Footer -->

  <a href="#" class="back-to-top d-flex align-items-center justify-content-center"><i
      class="bi bi-arrow-up-short"></i></a>

  <!-- Vendor JS Files -->
  <script src="assets/vendor/bootstrap/js/bootstrap.bundle.js"></script>
  <script src="assets/vendor/aos/aos.js"></script>
  <script src="assets/vendor/php-email-form/validate.js"></script>
  <script src="assets/vendor/swiper/swiper-bundle.min.js"></script>
  <script src="assets/vendor/purecounter/purecounter.js"></script>
  <script src="assets/vendor/isotope-layout/isotope.pkgd.min.js"></script>
  <script src="assets/vendor/glightbox/js/glightbox.min.js"></script>

  <!-- Template Main JS File -->
  <script src="assets/js/main.js"></script>

</body>

</html>